Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Association of caveolin-1 and -2 genetic variants and post-treatment serum caveolin-1 with prostate cancer risk and outcomes.

The Prostate - 15 Jun 2010

Langeberg Wendy J, Tahir Salahaldin A, Feng Ziding, Kwon Erika M, Ostrander Elaine A, Thompson Timothy C, Stanford Janet L

Abstract excerpt

BACKGROUND: Caveolin-1 (cav-1) is overexpressed by metastatic prostate cancer (PC) cells. Pre-operative serum cav-1 levels have been shown to be a prognostic marker for PC recurrence. This study evaluated the relationship between post-treatment serum cav-1 levels and single nucleotide polymorphis...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Caveolin 1
Share to Enzyme-Linked Immunosorbent Assay
Share to Neoplasm Recurrence, Local

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Proportional Hazards Models

Share to Prostatic Neoplasms

Share to Regression Analysis

Share to Risk Assessment

Share to SEER Program

Source

Open in PubMed Open full text

Identifiers

PMID: 20209490
DOI: 10.1002/pros.21137
PMCID: PMC2875326

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-20209490-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Association of caveolin-1 and -2 genetic variants and post-treatment serum caveolin-1 with prostate cancer risk and outcomes.PMID 20209490Read ↗

Vitamin D pathway gene variants and prostate cancer prognosis.Semantic proximity Read ↗

Prostate Cancer, Genetic Susceptibility, and Risk of Chronic Non-Urological Complications.Semantic proximity Read ↗

Significant association of caveolin-1 (CAV1) genotypes with prostate cancer susceptibility in Taiwan.Semantic proximity Read ↗

Calcium intake, polymorphisms of the calcium-sensing receptor, and recurrent/aggressive prostate cancer.Semantic proximity Read ↗

Genetic associations of visfatin polymorphisms with clinicopathologic characteristics of prostate cancer in Taiwanese males.Semantic proximity Read ↗

Replication of a genetic variant for prostate cancer-specific mortality.Semantic proximity Read ↗

Common genetic variation of the calcium-sensing receptor and lethal prostate cancer risk.Semantic proximity Read ↗

Association of a CAV-1 haplotype to familial aggressive prostate cancer.Semantic proximity Read ↗

Association of HPC2/ELAC2 polymorphisms with risk of prostate cancer in a population-based study.Semantic proximity Read ↗

Circulating vitamin D, vitamin D-related genetic variation, and risk of fatal prostate cancer in the National Cancer Institute Breast and Prostate Cancer Cohort Consortium.Semantic proximity Read ↗

Association between genetically proxied PCSK9 inhibition and prostate cancer risk: A Mendelian randomisation study.Semantic proximity Read ↗

Paraoxonase 1 (PON1) polymorphisms and prostate cancer in the CPS-II Nutrition Cohort.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.